TABLE 6.
Summary of AEs for Cefaclor granule and Cefaclor suspension in postprandial trial.
| AE category | Cefaclor granule | Cefaclor suspension | ||
|---|---|---|---|---|
| N | n | N | n | |
| Total adverse events | 2 | 2 | 1 | 1 |
| AEs related to the study drugs | 2 | 2 | 1 | 1 |
| Anemia | 1 | 1 | 0 | 0 |
| Infection urinary tract | 0 | 0 | 0 | 0 |
| Urinary occult blood positive | 1 | 1 | 1 | 1 |
| AEs of grade 1 | 2 | 2 | 1 | 1 |
| AEs of grade 2 | 0 | 0 | 0 | 0 |
| AEs of grade 3 and above | 0 | 0 | 0 | 0 |
| AEs leading to discontinuation of study drug | 0 | 0 | 0 | 0 |
N, number of the subjects with adverse events; n, the number of adverse events; AEs, adverse events.